Literature DB >> 26683666

HIV Promotes NLRP3 Inflammasome Complex Activation in Murine HIV-Associated Nephropathy.

Shabirul Haque1, Xiqian Lan1, Hongxiu Wen1, Rivka Lederman1, Amrita Chawla1, Mohamed Attia1, Ramchandra P Bongu1, Mohammad Husain2, Joanna Mikulak3, Moin A Saleem4, Waldemar Popik5, Ashwani Malhotra1, Praveen N Chander6, Pravin C Singhal7.   

Abstract

Dysregulated growth and loss of podocytes are important features of HIV-associated nephropathy. Recently, HIV was reported to induce a new type of programed cell death, pyroptosis, in T lymphocytes through induction of Nod-like receptor protein 3 (NLRP3) inflammasome complexes. We evaluated the role of HIV in podocyte NLRP3 inflammasome formation both in vivo and in vitro. Renal cortical sections of HIV-transgenic mice (Tg26) displayed increased expression of NLRP3, ASC (a CARD protein), caspase-1, and IL-1β proteins, confirming NLRP3 inflammasome complex formation in podocytes of Tg26 mice. Renal tissues of Tg26 mice also displayed enhanced mRNA levels and protein expressions of inflammasome markers (NLRP3, ASC, and caspase-1, and IL-1β). Serum of Tg26 mice also showed elevated concentrations of IL-1β cytokine compared with FVBN mice. HIV induced pyroptosis in a dose- and time-dependent manner within podocytes, a phenotype of inflammasome activation. Caspase-1 inhibitor not only attenuated podocyte expression of caspase-1 and IL-1β but also provided protection against pyroptosis, suggesting that HIV-induced podocyte injury was mediated by caspase-1 activation. Interestingly, HIV-induced podocyte pyroptosis could be partially inhibited by Tempol (a superoxide dismutase-mimetic agent) and by glyburide (an inhibitor of potassium efflux). These findings suggest that generation of reactive oxygen species and potassium efflux contribute to HIV-induced pyroptosis and NLRP3 inflammasome activation in podocytes.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26683666      PMCID: PMC4729234          DOI: 10.1016/j.ajpath.2015.10.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.

Authors:  Moin A Saleem; Michael J O'Hare; Jochen Reiser; Richard J Coward; Carol D Inward; Timothy Farren; Chang Ying Xing; Lan Ni; Peter W Mathieson; Peter Mundel
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

2.  Population-based risk assessment of APOL1 on renal disease.

Authors:  David J Friedman; Julia Kozlitina; Giulio Genovese; Prachi Jog; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

Review 3.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 4.  Caspase-1-induced pyroptotic cell death.

Authors:  Edward A Miao; Jayant V Rajan; Alan Aderem
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

5.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Adverse host factors exacerbate occult HIV-associated nephropathy.

Authors:  Dileep Kumar; Divya Salhan; Sandeep Magoon; Deepti D Torri; Swapna Sayeneni; Ankita Sagar; Anshu Bandhlish; Ashwani Malhotra; Praveen N Chander; Pravin C Singhal
Journal:  Am J Pathol       Date:  2011-08-24       Impact factor: 4.307

Review 7.  Central roles of NLRs and inflammasomes in viral infection.

Authors:  Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2010-09-17       Impact factor: 53.106

Review 8.  The inflammasome NLRs in immunity, inflammation, and associated diseases.

Authors:  Beckley K Davis; Haitao Wen; Jenny P-Y Ting
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

9.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

10.  Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.

Authors:  Jochen Reiser; Jun Oh; Isao Shirato; Katsuhiko Asanuma; Andreas Hug; Thomas M Mundel; Karen Honey; Kazumi Ishidoh; Eiki Kominami; Jordan A Kreidberg; Yasuhiko Tomino; Peter Mundel
Journal:  J Biol Chem       Date:  2004-06-14       Impact factor: 5.157

View more
  31 in total

Review 1.  APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  Trends Mol Med       Date:  2018-06-07       Impact factor: 11.951

2.  Hedgehog pathway plays a vital role in HIV-induced epithelial-mesenchymal transition of podocyte.

Authors:  Xiqian Lan; Hongxiu Wen; Kang Cheng; Andrei Plagov; Seyedeh Shadafarin Marashi Shoshtari; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2017-01-31       Impact factor: 3.905

3.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

4.  In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models.

Authors:  Chaoran Yin; Ting Zhang; Xiying Qu; Yonggang Zhang; Raj Putatunda; Xiao Xiao; Fang Li; Weidong Xiao; Huaqing Zhao; Shen Dai; Xuebin Qin; Xianming Mo; Won-Bin Young; Kamel Khalili; Wenhui Hu
Journal:  Mol Ther       Date:  2017-03-30       Impact factor: 11.454

5.  A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses.

Authors:  Melissa Kane; Felicity Deiss; Alexander Chervonsky; Tatyana V Golovkina
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.

Authors:  Alison C Kearns; Stephani Velasquez; Fengming Liu; Shen Dai; Yong Chen; Gabrielle Lehmicke; Jennifer Gordon; Jay Rappaport; Xuebin Qin
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

Review 7.  APOL1 and kidney cell function.

Authors:  Vinod Kumar; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

Review 8.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.

Authors:  Alok Jha; Vinod Kumar; Shabirul Haque; Kamesh Ayasolla; Shourav Saha; Xiqian Lan; Ashwani Malhotra; Moin A Saleem; Karl Skorecki; Pravin C Singhal
Journal:  FEBS J       Date:  2019-12-02       Impact factor: 5.542

10.  P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.

Authors:  Alexandra Y Soare; Natasha D Durham; Ramya Gopal; Benjamin Tweel; Kevin W Hoffman; Julia A Brown; Megan O'Brien; Nina Bhardwaj; Jean K Lim; Benjamin K Chen; Talia H Swartz
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.